Yili Chuanning BiotechnologyLtd Dividende
Zukünftiges Wachstum Kriterienprüfungen 3/6
Yili Chuanning BiotechnologyLtd is a dividend paying company with a current yield of 1.49% that is well covered by earnings.
Wichtige Informationen
1.6%
Dividendenausschüttung
-0.06%
Rückkaufsrendite
| Gesamte Aktionärsrendite | 1.5% |
| Zukünftige Dividendenrendite | 3.0% |
| Wachstum der Dividende | n/a |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | CN¥0.225 |
| Ausschüttungsquote | 37% |
Aktuelle Dividendenentwicklung
Recent updates
These 4 Measures Indicate That Yili Chuanning BiotechnologyLtd (SZSE:301301) Is Using Debt Safely
Oct 11
If EPS Growth Is Important To You, Yili Chuanning BiotechnologyLtd (SZSE:301301) Presents An Opportunity
Jul 23We Think Yili Chuanning BiotechnologyLtd (SZSE:301301) Can Manage Its Debt With Ease
May 31Yili Chuanning BiotechnologyLtd (SZSE:301301) Could Easily Take On More Debt
Feb 26Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Whilst dividend payments have been stable, 301301 has been paying a dividend for less than 10 years.
Wachsende Dividende: 301301's dividend payments have increased, but the company has only paid a dividend for 2 years.
Dividendenrendite im Vergleich zum Markt
| Yili Chuanning BiotechnologyLtd Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (301301) | 1.6% |
| Untere 25 % des Marktes (CN) | 0.6% |
| Markt Top 25 % (CN) | 2.2% |
| Branchendurchschnitt (Biotechs) | 1.2% |
| Analystenprognose (301301) (bis zu 3 Jahre) | 3.0% |
Bemerkenswerte Dividende: 301301's dividend (1.49%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Hohe Dividende: 301301's dividend (1.49%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: With its reasonably low payout ratio (37%), 301301's dividend payments are well covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: With its reasonable cash payout ratio (59.3%), 301301's dividend payments are covered by cash flows.